Cardiovascular disease is the leading contributor to years lost due to disability or premature death among adults. Current efforts focus on risk prediction and risk factor mitigation‚ which have been ...

WORLD OF EVS EVs are 30- to 1000-nm-sized membranous structures released by cells into the extracellular space (Figure 1). Their membrane, composed of a complex lipid and protein repertoire, ...

BACKGROUND: Upper extremity (UE) motor function impairment is a major poststroke complication whose recovery remains one of the most challenging tasks in neurological rehabilitation. This study ...

Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and mortality. There have been significant management advances over the past 2 decades, but the burden ...

There is a growing appreciation for differences in epidemiology, treatment, and outcomes of cardiovascular conditions by sex. Historically, cardiovascular clinical trials have under-represented ...

The past decade has seen increasing interest in the tricuspid valve (TV), once referred to as the forgotten valve, as a result of a combination of improved imaging and therapeutic possibilities plus a ...

For >50 years, immune cells, comprised of lymphocytes and myeloid-like cells, have been observed in blood vessels and kidneys of humans with hypertension, and various experimental models, including ...

BACKGROUND: Although heart failure with preserved ejection fraction (HFpEF) has become the predominant heart failure subtype, it remains clinically under-recognized. HFpEF diagnosis is particularly ...

Aim: This executive summary of the clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain ...

Aortic valves from EgfrVel/+ mice and control mice were examined by light microscopy at 2.5 to 4 months of age. Additional EgfrVel/+ and control mice underwent echocardiography at 2.5, 4.5, 8, and 12 ...

Abstract —Short-term feeding (up to 7 days) of an atherogenic diet to C57BL/6 low density lipoprotein receptor–deficient mice did not result in decreased hepatic paraoxonase (PON) mRNA but caused a ...